Inspire Medical Systems stock analysis (INSP)
Research Inspire Medical Systems's valuation, financial performance, ownership activity and company fundamentals.
Key company data
- Latest recorded price: $50.02 on 2026-07-30
- Market capitalization: $1.47B
- Price-to-earnings ratio: 11.79
- Analyst target price: $51.43
- Sector: Health Care Technology
About Inspire Medical Systems
Inspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for patients with moderate to severe OSA. It also develops a novel, closed-loop solution that continuously monitors a patient's breathing and delivers mild hypoglossal nerve stimulation to maintain an open airway. The company was incorporated in 2007 and is headquartered in Golden Valley, Minnesota.
Data last updated: